With a background spanning Boston Consulting Group, Novartis and Silicon Valley, Michelle Wu is a leader at the forefront of AI in MedTech. Today, she’s the co-founder and CEO of NyquistAI and recognised as one of the top 100 women in AI globally.

Michelle believes that successful AI adoption has far less to do with the technology, and far more to do with people. Mindset, culture and clarity matter more than tools - and the companies who get this right will move fastest.

With a career shaped by data, strategy and innovation, Michelle offers an honest look at what AI can (and can’t) do for regulatory affairs, and how leaders can turn ambition into real impact.

Tune in for:

• Why 86% of leaders are struggling with AI
• The three factors every company needs for real adoption
• How to avoid AI fatigue and overload
• What AI will really change in regulatory careers
• Why mindset, structure and data matter more than hype
  And much more!

Want to build real GenAI capability in RA?

Apply for elemed’s AI Accelerator 2026: a focused programme where RA leaders pilot one workflow inside real work and measure the impact.

Request access 👉 https://www.elemed.eu/request-access-ai-accelerator/#request-form

Requests are reviewed and seats are limited.

Career inspiration, medtech opportunities, hiring solutions and market insights, all in one place. Find them here.